Ebola

1 December 2020

How small clinical trial sample sizes can offer important findings

Scientists have been racing to develop COVID-19 vaccines that could reach millions, yet many of the studies have surprisingly small sample sizes drawn from the clinical trials. Does that matter?

18 November 2020

From biodefence to the DRC: How the Ebola vaccine became one of the fastest vaccines to license in history

COVID-19 vaccines are set to become the quickest vaccines in history to go from initial trials to rollout, but what lessons can we learn from its speedy predecessor: the Ebola vaccine?

22 October 2020

New vaccines to meet emerging needs

Here’s how Gavi helps lower-income countries get the new vaccines and products they need to address urgent threats to public health – from cholera and COVID-19, to Ebola and pneumonia.

23 September 2020

Leaders in the fight against infectious diseases

Snapshots from DRC, India and Zambia illustrate country ownership and progress in the fights against Ebola, polio and HPV.

4 August 2020

How creative communication strategies are helping fight COVID-19 misinformation in DRC

The misinformation surrounding COVID-19 in the Democratic Repubic of the Congo isn’t new – public health officials have seen rumours and myths circulate with Ebola. Here’s how they are tackling them.

16 July 2020

The vaccines success story gives us hope for the future

As the world waits for a vaccine to defeat the COVID-19 pandemic, we look back to all that vaccines have achieved for humanity.

Subscribe to our newsletter